Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Publication year range
1.
J Endocrinol ; 256(3)2023 03 01.
Article in English | MEDLINE | ID: mdl-36622663

ABSTRACT

Breast cancer (BC) is the most diagnosed cancer in women worldwide. In estrogen receptor (ER)-positive disease, anti-estrogens and aromatase inhibitors (AI) improve patient survival; however, many patients develop resistance. Dysregulation of apoptosis is a common resistance mechanism; thus, agents that can reinstate the activity of apoptotic pathways represent promising therapeutics for advanced drug-resistant disease. Emerging targets in this scenario include microRNAs (miRs). To identify miRs modulating apoptosis in drug-responsive and -resistant BC, a high-throughput miR inhibitor screen was performed, followed by high-content screening microscopy for apoptotic markers. Validation demonstrated that miR-361-3p inhibitor significantly increases early apoptosis and reduces proliferation of drug-responsive (MCF7), plus AI-/antiestrogen-resistant derivatives (LTED, TamR, FulvR), and ER- cells (MDA-MB-231). Importantly, proliferation-inhibitory effects were observed in vivo in a xenograft model, indicating the potential clinical application of miR-361-3p inhibition. RNA-seq of tumour xenografts identified FANCA as a direct miR-361-3p target, and validation suggested miR-361-3p inhibitor effects might be mediated in part through FANCA modulation. Moreover, miR-361-3p inhibition resulted in p53-mediated G1 cell cycle arrest through activation of p21 and reduced BC invasion. Analysis of publicly available datasets showed miR-361-3p expression is significantly higher in primary breast tumours vspaired normal tissue and is associated with decreased overall survival. In addition, miR-361-3p inhibitor treatment of BC patient explants decreased levels of miR-361-3p and proliferation marker, Ki67. Finally, miR-361-3p inhibitor showed synergistic effects on BC growth when combined with PARP inhibitor, Olaparib. Together, these studies identify miR-361-3p inhibitor as a potential new treatment for drug-responsive and -resistant advanced BC.


Subject(s)
Breast Neoplasms , MicroRNAs , Humans , Female , Breast Neoplasms/drug therapy , Breast Neoplasms/genetics , Breast Neoplasms/pathology , Drug Resistance, Neoplasm/genetics , MicroRNAs/genetics , MicroRNAs/metabolism , Estrogen Antagonists/pharmacology , Aromatase Inhibitors/pharmacology , Aromatase Inhibitors/therapeutic use , Apoptosis/genetics , Cell Proliferation , Gene Expression Regulation, Neoplastic , Cell Line, Tumor
2.
Oxid Med Cell Longev ; 2019: 4654206, 2019.
Article in English | MEDLINE | ID: mdl-31485292

ABSTRACT

The continuous exposure of the human body's cells to radiation and genotoxic stresses leads to the accumulation of DNA lesions. Fortunately, our body has several effective repair mechanisms, among which is nucleotide excision repair (NER), to counteract these lesions. NER includes both global genome repair (GG-NER) and transcription-coupled repair (TC-NER). Deficiencies in the NER pathway underlie the development of several DNA repair diseases, such as xeroderma pigmentosum (XP), Cockayne syndrome (CS), and trichothiodystrophy (TTD). Deficiencies in GG-NER and TC-NER render individuals to become prone to cancer and neurological disorders, respectively. Therefore, NER regulation is of interest in fine-tuning these risks. Distinct signaling cascades including the NFE2L2 (NRF2), AHR, PI3K/AKT1, MAPK, and CSNK2A1 pathways can modulate NER function. In addition, several chemical and biological compounds have proven success in regulating NER's activity. These modulators, particularly the positive ones, could therefore provide potential treatments for genetic DNA repair-based diseases. Negative modulators, nonetheless, can help sensitize cells to killing by genotoxic chemicals. In this review, we will summarize and discuss the major upstream signaling pathways and molecules that could modulate the NER's activity.


Subject(s)
Cockayne Syndrome/metabolism , DNA Damage , DNA Repair , Signal Transduction , Trichothiodystrophy Syndromes/metabolism , Ultraviolet Rays/adverse effects , Xeroderma Pigmentosum/metabolism , Animals , Cockayne Syndrome/pathology , Humans , Trichothiodystrophy Syndromes/pathology , Xeroderma Pigmentosum/pathology
4.
Oncogene ; 36(4): 446-457, 2017 01 26.
Article in English | MEDLINE | ID: mdl-27375018

ABSTRACT

Melanoma is the deadliest form of skin cancer owing to its proclivity to metastasise, and recently developed therapies have not yielded the expected results, because almost all patients relapse. Therefore, understanding the molecular mechanisms that underlie early invasion by melanoma cells is crucial to improving patient survival. We have previously shown that, whereas the Tetraspanin 8 protein (Tspan8) is undetectable in normal skin and benign lesions, its expression arises with the progression of melanoma and is sufficient to increase cell invasiveness. Therefore, to identify Tspan8 transcriptional regulators that could explain the onset of Tspan8 expression, thereby conferring an invasive phenotype, we performed an innovative RNA interference-based screen, which, for the first time, identified several Tspan8 repressors and activators, such as GSK3ß, PTEN, IQGAP1, TPT1 and LCMR1. LCMR1 is a recently identified protein that is overexpressed in numerous carcinomas; its expression and role, however, had not previously been studied in melanoma. The present study identified Tspan8 as the first LCMR1 target that could explain its function in carcinogenesis. LCMR1 modulation was sufficient to positively regulate endogenous Tspan8 expression, with concomitant in vitro phenotypic changes such as loss of melanoma cell-matrix adherence and increase in invasion, and Tspan8 expression promoted tumourigenicity in vivo. Moreover, LCMR1 and Tspan8 overexpression were shown to correlate in melanoma lesions, and both proteins could be downregulated in vitro by vemurafenib. In conclusion, this study highlights the importance of Tspan8 and its regulators in the control of early melanoma invasion and suggests that they may be promising new therapeutic targets downstream of the RAF-MEK-ERK signalling pathway.


Subject(s)
Mediator Complex/genetics , Melanoma/pathology , Skin Neoplasms/pathology , Tetraspanins/genetics , Animals , Cell Line, Tumor , Heterografts , Humans , Male , Mediator Complex/metabolism , Melanoma/genetics , Melanoma/metabolism , Mice , Mice, Nude , Neoplasm Invasiveness , RNA Interference , Signal Transduction , Skin Neoplasms/genetics , Skin Neoplasms/metabolism , Tetraspanins/metabolism , Transfection , Tumor Protein, Translationally-Controlled 1
5.
Sci Rep ; 4: 5942, 2014 Aug 06.
Article in English | MEDLINE | ID: mdl-25096726

ABSTRACT

Quantification of basic cell functions is a preliminary step to understand complex cellular mechanisms, for e.g., to test compatibility of biomaterials, to assess the effectiveness of drugs and siRNAs, and to control cell behavior. However, commonly used quantification methods are label-dependent, and end-point assays. As an alternative, using our lensfree video microscopy platform to perform high-throughput real-time monitoring of cell culture, we introduce specifically devised metrics that are capable of non-invasive quantification of cell functions such as cell-substrate adhesion, cell spreading, cell division, cell division orientation and cell death. Unlike existing methods, our platform and associated metrics embrace entire population of thousands of cells whilst monitoring the fate of every single cell within the population. This results in a high content description of cell functions that typically contains 25,000 - 900,000 measurements per experiment depending on cell density and period of observation. As proof of concept, we monitored cell-substrate adhesion and spreading kinetics of human Mesenchymal Stem Cells (hMSCs) and primary human fibroblasts, we determined the cell division orientation of hMSCs, and we observed the effect of transfection of siCellDeath (siRNA known to induce cell death) on hMSCs and human Osteo Sarcoma (U2OS) Cells.


Subject(s)
Fibroblasts/physiology , Mesenchymal Stem Cells/physiology , Microscopy, Video/methods , Osteoblasts/metabolism , Video Recording/methods , Cell Adhesion , Cell Count , Cell Death/genetics , Cell Division , Cell Line, Tumor , Fibroblasts/cytology , Humans , Mesenchymal Stem Cells/cytology , Microscopy, Video/instrumentation , Osteoblasts/pathology , Primary Cell Culture , RNA, Small Interfering/genetics , RNA, Small Interfering/metabolism , Video Recording/instrumentation
6.
Cell Death Differ ; 21(1): 59-68, 2014 Jan.
Article in English | MEDLINE | ID: mdl-23787997

ABSTRACT

The exposure of calreticulin (CRT) on the surface of stressed and dying cancer cells facilitates their uptake by dendritic cells and the subsequent presentation of tumor-associated antigens to T lymphocytes, hence stimulating an anticancer immune response. The chemotherapeutic agent mitoxantrone (MTX) can stimulate the peripheral relocation of CRT in both human and yeast cells, suggesting that the CRT exposure pathway is phylogenetically conserved. Here, we show that pheromones can act as physiological inducers of CRT exposure in yeast cells, thereby facilitating the formation of mating conjugates, and that a large-spectrum inhibitor of G protein-coupled receptors (which resemble the yeast pheromone receptor) prevents CRT exposure in human cancer cells exposed to MTX. An RNA interference screen as well as transcriptome analyses revealed that chemokines, in particular human CXCL8 (best known as interleukin-8) and its mouse ortholog Cxcl2, are involved in the immunogenic translocation of CRT to the outer leaflet of the plasma membrane. MTX stimulated the production of CXCL8 by human cancer cells in vitro and that of Cxcl2 by murine tumors in vivo. The knockdown of CXCL8/Cxcl2 receptors (CXCR1/Cxcr1 and Cxcr2) reduced MTX-induced CRT exposure in both human and murine cancer cells, as well as the capacity of the latter-on exposure to MTX-to elicit an anticancer immune response in vivo. Conversely, the addition of exogenous Cxcl2 increased the immunogenicity of dying cells in a CRT-dependent manner. Altogether, these results identify autocrine and paracrine chemokine signaling circuitries that modulate CRT exposure and the immunogenicity of cell death.


Subject(s)
Calreticulin/metabolism , Interleukin-8/metabolism , Saccharomyces cerevisiae Proteins/metabolism , Animals , Antineoplastic Agents/therapeutic use , Antineoplastic Agents/toxicity , Apoptosis/drug effects , Cell Line, Tumor , Chemokine CXCL2/metabolism , Dendritic Cells/immunology , Dendritic Cells/metabolism , HCT116 Cells , HeLa Cells , Humans , Interleukin-8/antagonists & inhibitors , Interleukin-8/genetics , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mitoxantrone/therapeutic use , Mitoxantrone/toxicity , Neoplasms/drug therapy , Neoplasms/metabolism , Neoplasms/pathology , Receptors, Interleukin-8A/antagonists & inhibitors , Receptors, Interleukin-8A/genetics , Receptors, Interleukin-8A/metabolism , Receptors, Interleukin-8B/antagonists & inhibitors , Receptors, Interleukin-8B/genetics , Receptors, Interleukin-8B/metabolism , Saccharomyces cerevisiae/classification , Saccharomyces cerevisiae/metabolism , Signal Transduction , Transcriptome/drug effects
7.
Exp Hematol ; 27(5): 845-52, 1999 May.
Article in English | MEDLINE | ID: mdl-10340400

ABSTRACT

Arsenic trioxide (As2O3) has been demonstrated to be effective for the treatment of acute promyelocytic leukemia (APL) and to inhibit proliferation and produce apoptosis in the APL cell line NB4. To determine if As2O3 might be useful for the treatment of other lineages, we investigated the effects of As2O3 on viability, proliferation, and induction of apoptosis in the megakaryocytic leukemia cell lines HEL, Meg-01, UT7, and M07e. Our results showed that As2O3, at concentrations of 0.1-2.0 microM, causes a dose- and time-dependent inhibition of survival and growth in all four megakaryocytic leukemia cell lines studied. In contrast, As2O3 at similar concentrations had no effects on either viability or growth of the nonmegakaryocytic leukemia cell line HL60 and two human breast cancer cell lines, ZR75 and MCF7. In situ end-labeling of DNA fragments (TUNEL assay) indicated that As2O3, at concentrations of 0.5-2 microM, could significantly induce apoptosis in the aforementioned four megakaryocytic leukemia cell lines, but not in the nonmegakaryocytic HL60, ZR75, and MCF7 cell lines. These results were confirmed using conventional morphologic assessment and the DNA ladder assay. Induction of apoptosis in arsenic-treated Meg-01 and UT7 cells was accompanied by a dose-response decrease of Bcl-2 protein, whereas As2O3 had no effect on this measurement in HL60, ZR75, and MCF7 cell lines. Pertinently, these concentrations of As2O3 produced identical changes in the characteristics of the APL cell line NB4. Collectively, these data demonstrate that As2O3 can selectively inhibit growth and induce apoptosis in megakaryocytic leukemia cell lines. The use of As2O3 for the treatment of malignant megakaryocytic disorders should be considered.


Subject(s)
Apoptosis/drug effects , Arsenicals/pharmacology , Cell Division/drug effects , Cell Survival/drug effects , Leukemia, Megakaryoblastic, Acute/pathology , Oxides/pharmacology , Arsenic Trioxide , Breast Neoplasms/genetics , Breast Neoplasms/pathology , Gene Expression Regulation, Neoplastic/drug effects , Genes, bcl-2 , HL-60 Cells , Humans , In Situ Nick-End Labeling , Leukemia, Megakaryoblastic, Acute/genetics , Tumor Cells, Cultured
8.
J Biol Chem ; 273(45): 29786-93, 1998 Nov 06.
Article in English | MEDLINE | ID: mdl-9792693

ABSTRACT

Although cadherins appear to be necessary for proper cell-cell contacts, the physiological role of VE-cadherin (vascular endothelium cadherin) in adult tissue has not been clearly determined. To shed some light on this question, we have disturbed the adhesive function of VE-cadherin in human endothelial cell culture using a polyclonal anti-VE-cadherin antibody. This antibody disrupts confluent endothelial cell monolayers in vitro and transiently generates numerous gaps at cell-cell junctions. The formation of these gaps correlates with a reversible increase in the monolayer permeability. We present evidence that destruction of the homotypic interactions between the extracellular domains of VE-cadherin induces a rapid resynthesis of VE-cadherin, leading to restoration of endothelial cell-cell contacts. The expression of new molecules of VE-cadherin correlates with a modest but significant increase in VE-cadherin mRNA synthesis. Altogether, these results establish a critical role for VE-cadherin in the maintenance and restoration of endothelium integrity.


Subject(s)
Cadherins/biosynthesis , Endothelium, Vascular/metabolism , Amino Acid Sequence , Antigens, CD , Base Sequence , Cadherins/genetics , Cadherins/immunology , Cell Adhesion , Cell Membrane Permeability , Cells, Cultured , DNA Primers , Endothelium, Vascular/cytology , Humans , Microscopy, Fluorescence , Molecular Sequence Data , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , RNA, Messenger/metabolism
9.
Ann Endocrinol (Paris) ; 57(3): 139-46, 1996.
Article in French | MEDLINE | ID: mdl-8949405

ABSTRACT

In this paper, two adhesive receptors are presented. The first one, the integrin alpha IIb beta 3 is implied in platelet aggregation following vascular damage. The second one is the VE-cadherin, which is specifically expressed on endothelial cells and participates in the maintenance of endothelium integrity. Their structures and their physiological roles are discussed.


Subject(s)
Cadherins/metabolism , Integrins/metabolism , Antigens, CD , Cadherins/ultrastructure , Humans , Platelet Aggregation , Platelet Glycoprotein GPIIb-IIIa Complex/metabolism , Platelet Glycoprotein GPIIb-IIIa Complex/ultrastructure
SELECTION OF CITATIONS
SEARCH DETAIL
...